BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Batista LAF, Silva KJS, da Costa E Silva LM, de Moura YF, Zucchi FCR. Tuberculosis: A granulomatous disease mediated by epigenetic factors. Tuberculosis (Edinb) 2020;123:101943. [PMID: 32741528 DOI: 10.1016/j.tube.2020.101943] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Cabral N, de Figueiredo V, Gandini M, de Souza CF, Medeiros RA, Lery LMS, Lara FA, de Macedo CS, Pessolani MCV, Pereira GMB. Modulation of the Response to Mycobacterium leprae and Pathogenesis of Leprosy. Front Microbiol 2022;13:918009. [PMID: 35722339 DOI: 10.3389/fmicb.2022.918009] [Reference Citation Analysis]
2 Nishiuchi Y, Tateishi Y, Hirano H, Ozeki Y, Yamaguchi T, Miki M, Kitada S, Maruyama F, Matsumoto S. Direct Attachment with Erythrocytes Augments Extracellular Growth of Pathogenic Mycobacteria. Microbiol Spectr 2022;:e0245421. [PMID: 35293805 DOI: 10.1128/spectrum.02454-21] [Reference Citation Analysis]
3 Bresser PL, Reed J, Sathekge MM, Vorster M. 68 Ga-nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series. J Med Radiat Sci 2022. [PMID: 35760568 DOI: 10.1002/jmrs.603] [Reference Citation Analysis]
4 Gauba K, Gupta S, Shekhawat J, Sharma P, Yadav D, Banerjee M. Immunomodulation by epigenome alterations in Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2021;128:102077. [PMID: 33812175 DOI: 10.1016/j.tube.2021.102077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang X, Xie Q, Ye Z, Li Y, Che Z, Huang M, Zeng J. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities. Front Immunol 2021;12:695278. [PMID: 34367155 DOI: 10.3389/fimmu.2021.695278] [Reference Citation Analysis]
6 Silwal P, Paik S, Kim JK, Yoshimori T, Jo EK. Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection. Front Cell Infect Microbiol 2021;11:633360. [PMID: 33828998 DOI: 10.3389/fcimb.2021.633360] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Maison DP. Tuberculosis pathophysiology and anti-VEGF intervention. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2022;27:100300. [DOI: 10.1016/j.jctube.2022.100300] [Reference Citation Analysis]
8 Sui J, Qiao W, Xiang X, Luo Y. Epigenetic Changes in Mycobacterium tuberculosis and its Host Provide Potential Targets or Biomarkers for Drug Discovery and Clinical Diagnosis. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106195] [Reference Citation Analysis]
9 Figueira MBA, de Lima DS, Boechat AL, Filho MGDN, Antunes IA, Matsuda JDS, Ribeiro TRA, Felix LS, Gonçalves ASF, da Costa AG, Ramasawmy R, Pontillo A, Ogusku MM, Sadahiro A. Single-Nucleotide Variants in the AIM2 - Absent in Melanoma 2 Gene (rs1103577) Associated With Protection for Tuberculosis. Front Immunol 2021;12:604975. [PMID: 33868225 DOI: 10.3389/fimmu.2021.604975] [Reference Citation Analysis]